We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
60 result(s) found, displaying 31 to 40
-
Prescription medicine registrationActive ingredients: cabozantinib (S)-malate.
-
Prescription medicine registrationActive ingredients: triptorelin embonate.
-
Prescription medicine registrationActive ingredients: triptorelin embonate.
-
-
Cancellation by sponsorRequested by Ipsen Pty Ltd
-
Prescription medicine registrationActive ingredients: clostridium botulinum type a toxin haemagglutinin complex.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CABOMETYX cabozantinib (as (S)-malate) 40 mg film-coated tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CABOMETYX cabozantinib (as (S)-malate) 60 mg film-coated tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CABOMETYX cabozantinib (as (S)-malate) 20 mg film-coated tablet bottle.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Mecasermin